Tempest Therapeutics, Inc. Cash and Cash Equivalents, Fair Value Disclosure
Tempest Therapeutics, Inc. (TPST) had Cash and Cash Equivalents, Fair Value Disclosure of $6.41 million as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2015-03-16
- 2014-12-31: Cash and Cash Equivalents, Fair Value Disclosure $6.41M.
- 2014-06-30: Cash and Cash Equivalents, Fair Value Disclosure $12.13M; Cash and Cash Equivalents, Fair Value Disclosure as first filed $16.55M.
- 2014-03-31: Cash and Cash Equivalents, Fair Value Disclosure $56.13M.
- 2013-12-31: Cash and Cash Equivalents, Fair Value Disclosure $18.08M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure | Cash and Cash Equivalents, Fair Value Disclosure as first filed |
|---|---|---|
| 2014-12-31 | $6.41M 10-K · filed 2015-03-16 | |
| 2014-06-30 | $12.13M 10-Q · filed 2014-11-10 | $16.55M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $56.13M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $18.08M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $21.08M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $28.19M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $43.19M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $14.78M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |